Open access
Aug 2026
Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles
Blood‐based biomarkers are essential for early detection, monitoring, and therapeutic development in Alzheimer's disease (AD) and related dementia (ADRD), but current assays lack brain cell specificity and sensitivity to low‐abundant proteins.
Ashish Kumar, Mitu Sharma, Yixin Su et al.
· Alzheimer's & Dementia · 0 citations